Form 4 for ATEX Anterix Inc.
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001209191-21-053361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-25 | 2021-08-23 | ATEX | Schwartz Robert Harris | Pres, CEO, Dir | A - Grant | $0.00 | +50.0K | 131.4K | +61% | $0 |
| D | 2021-08-25 | 2021-08-23 | ATEX | Schwartz Robert Harris | Pres, CEO, Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | A | A | 50,000 | $0.00 | 131,383 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-23 | A | A | 100,000 | $0.00 | 100,000 | D | $57.00 · — to 2031-08-23 | 100,000 Common Stock | (F2) 25% of the option shares vest and become exercisable on August 23, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. |